# US 2025/0029729 A1 · Machine learning-based risk-classification of endomerial cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0029729 A1
- Document ID: US20250029729A1
- Status: Published application
- Kind: A1
- Application number: 18/780,061
- Filed: 2024-07-22
- Published: 2025-01-23
- Earliest claimed: 2023-07-20
- Applicants: Northwestern University
- Inventors: Shuhua Zheng; Eric Donald Donnelly; Jonathan B. Strauss
- Web page: https://patentgrep.com/patent/US20250029729A1

## CPC

- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Endometrial cancer is classified and/or risk stratified using a suitably trained machine learning model. Risk classification of endometrial cancer is provided using a machine learning-based analysis of patient health data, such as clinicopathologic data, molecular data, and the like. Risk assessment is optimized for endometrial cancer, including risk of nodal involvement, distant metastasis, disease progression, and overall survival.

## Claims

### Claim 1

A method for risk stratifying a patient for endometrial cancer using machine learning, comprising:
accessing patient health data for a patient with a computer system;
accessing a machine learning model with the computer system, wherein the machine learning model has been trained on training data to generate classified feature data based on features present in a patient's patient health data;
applying the patient health data to the machine learning model, generating an output as classified feature data that indicate at least one of a risk stratification or classification of endometrial cancer in the patient based on features in their patient health data; and
outputting the classified feature data with the computer system.

### Claim 2 (depends on 1)

The method of claim 1, wherein the machine learning model comprises an artificial neural network.

### Claim 3 (depends on 2)

The method of claim 2, wherein the artificial neural network is a deep neural network.

### Claim 4 (depends on 1)

The method of claim 1, further comprising selecting a subset of features from the patient health data and inputting only the subset of features to the machine learning model.

### Claim 5 (depends on 4)

The method of claim 4, wherein the subset of features is determined by training another machine learning model on patient health data collected from a cohort of patients.

### Claim 6 (depends on 4)

The method of claim 4, wherein the subset of features comprises patient demographic data and molecular data.

### Claim 7 (depends on 6)

The method of claim 6, wherein the patient demographic data comprises age and race.

### Claim 8 (depends on 6)

The method of claim 6, wherein the molecular data comprise at least one of TP53 status, mismatch repair (MMR) status, fraction genome altered (FGA), and mutation counts.

### Claim 9 (depends on 6)

The method of claim 6, wherein the subset of features further comprises at least one of histologic subtype or histologic grade.

### Claim 10 (depends on 1)

The method of claim 1, wherein the classified feature data comprise probability values for developing endometrial cancer.

### Claim 11 (depends on 1)

The method of claim 1, wherein the classified feature data comprise category labels indicating low, moderate, or high risk for developing endometrial cancer.

### Claim 12 (depends on 1)

The method of claim 1, wherein outputting the classified feature data comprises:
analyzing the classified feature data with the computer system to determine a risk for the patient developing endometrial cancer;
generating an order set for a follow up examination of the patient based on the determined risk for the patient developing endometrial cancer; and
outputting the order set to an electronic health record (EHR) of the patient using the computer system.

### Claim 13 (depends on 12)

The method of claim 12, wherein the determined risk for the patient developing endometrial cancer indicates a risk of nodal involvement for endometrial cancer in the patient and the order set indicates orders for examination to determine an extent of nodal involvement for endometrial cancer in the patient.

### Claim 14 (depends on 12)

The method of claim 12, wherein the order set indicates a treatment option for the patient based on the determined risk for the patient developing endometrial cancer.
